Equities

Novacyt SA

Novacyt SA

Actions
Health CareMedical Equipment and Services
  • Price (GBX)52.10
  • Today's Change-0.600 / -1.14%
  • Shares traded145.59k
  • 1 Year change-6.63%
  • Beta--
Data delayed at least 20 minutes, as of Nov 08 2024 16:22 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4487102
Total Receivables, Net373544
Total Inventory3.023.0311
Prepaid expenses2.602.422.03
Other current assets, total------
Total current assets86127159
Property, plant & equipment, net153.276.38
Goodwill, net216.6511
Intangibles, net103.123.71
Long term investments0.0600.14
Note receivable - long term------
Other long term assets--00.06
Total assets134141184
LIABILITIES
Accounts payable5.902.325.01
Accrued expenses1.11----
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.210.610.42
Other current liabilities, total212133
Total current liabilities302439
Total long term debt130.261.45
Total debt140.871.87
Deferred income tax2.241.041.22
Minority interest------
Other liabilities, total1.550.150.31
Total liabilities472642
SHAREHOLDERS EQUITY
Common stock4.054.054.05
Additional paid-in capital515151
Retained earnings (accumulated deficit)336187
Treasury stock - common(0.14)(0.09)(0.08)
Unrealized gain (loss)------
Other equity, total------
Total equity87115142
Total liabilities & shareholders' equity134141184
Total common shares outstanding717171
Treasury shares - common primary issue0.060.020.01
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.